Skip to Main Content
An official website of the United States government
Login Change: CDAS is now using the NIH Researcher Auth Service (RAS) to manage our existing login options. When logging into CDAS, you will be taken to RAS, where you can select your preferred login provider to access CDAS.

Mortality and Morbidity Following Prostate Biopsy

Principal Investigator

Name
Paul Pinsky

Institution
NCI, DCP, EDRG

Position Title
Researcher

Email
pp4f@nih.gov

About this CDAS Project

Study
PLCO (Learn more about this study)

Project ID
PLCO-12

Initial CDAS Request Approval
Jan 17, 2013

Title
Mortality and Morbidity Following Prostate Biopsy

Summary
We will examine mortality and complications following prostate biopsy in PLCO. For mortality, the death rate following prostate biopsy will be compared to that of an appropriate internal control group without biopsy.

Aims

1. To examine the mortality rate following prostate biopsy and compare to that of an appropriate internal control group. A model will be developed to control for possible confounders.

2. To examine complications following prostate biopsy.

Collaborators

Howard Parnes, NCI